Envision Healthcare Co. (EVHC) Shares Sold by Hahn Capital Management LLC

Hahn Capital Management LLC lessened its position in Envision Healthcare Co. (NYSE:EVHC) by 38.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 303,676 shares of the company’s stock after selling 189,552 shares during the quarter. Hahn Capital Management LLC owned 0.25% of Envision Healthcare worth $13,650,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of EVHC. Janus Henderson Group PLC boosted its position in Envision Healthcare by 36,086.8% during the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock valued at $247,239,000 after buying an additional 3,934,185 shares during the period. OZ Management LP purchased a new stake in shares of Envision Healthcare during the third quarter worth about $131,987,000. Maverick Capital Ltd. boosted its holdings in shares of Envision Healthcare by 66.2% during the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after purchasing an additional 2,028,026 shares during the period. Lord Abbett & CO. LLC boosted its holdings in shares of Envision Healthcare by 259.6% during the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after purchasing an additional 953,928 shares during the period. Finally, Westfield Capital Management Co. LP purchased a new stake in shares of Envision Healthcare during the second quarter worth about $45,892,000.

A number of analysts have recently weighed in on the stock. Citigroup lowered shares of Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 target price for the company. in a report on Thursday, November 2nd. BidaskClub lowered shares of Envision Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. Bank of America decreased their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research note on Monday, October 9th. Piper Jaffray Companies began coverage on shares of Envision Healthcare in a research note on Wednesday. They issued a “neutral” rating and a $35.00 price target for the company. Finally, Canaccord Genuity reissued a “buy” rating and issued a $32.00 price target (down from $68.00) on shares of Envision Healthcare in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, seven have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $46.06.

Shares of Envision Healthcare Co. (NYSE EVHC) traded down $0.03 during midday trading on Thursday, hitting $33.37. 4,039,400 shares of the company’s stock were exchanged, compared to its average volume of 2,267,143. Envision Healthcare Co. has a fifty-two week low of $23.77 and a fifty-two week high of $73.00. The company has a market capitalization of $4,037.10, a P/E ratio of 10.31, a price-to-earnings-growth ratio of 0.87 and a beta of 0.57. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89.

Envision Healthcare (NYSE:EVHC) last announced its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. During the same period in the prior year, the business posted $1.13 EPS. Envision Healthcare’s revenue for the quarter was up 142.0% on a year-over-year basis. research analysts forecast that Envision Healthcare Co. will post 2.56 earnings per share for the current year.

Envision Healthcare announced that its Board of Directors has authorized a stock buyback plan on Monday, September 18th that permits the company to buyback $250.00 million in shares. This buyback authorization permits the company to reacquire up to 4.5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.

COPYRIGHT VIOLATION NOTICE: This article was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://stocknewstimes.com/2017/12/14/envision-healthcare-co-evhc-shares-sold-by-hahn-capital-management-llc.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply